Alexandre Gauthier, MD
Ophthalmology · Warrenton, VANPI 1710206057
Payments from drug & device makers
Across 56 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$372
- Astellas Pharma US Inc$149
- Bausch & Lomb Americas Inc.$143
- Tarsus Pharmaceuticals, Inc.$116
- Regeneron Healthcare Solutions, Inc.$97
- Alcon$95
- plus $323 from 9 others
What the payments were for
- Food & beverage$1,294100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $372 |
| Astellas Pharma US Inc | 7 | $149 |
| Bausch & Lomb Americas Inc. | 7 | $143 |
| Tarsus Pharmaceuticals, Inc. | 4 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| Alcon | 5 | $95 |
| Iridex Corporation | 2 | $86 |
| Genentech USA, Inc. | 3 | $62 |
| Eyevance Pharmaceuticals LLC | 2 | $43 |
| US Oncology Corporate, Inc. | 1 | $39 |
| Tearlab Corp | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Biogen | 1 | $20 |
| Oyster Point Pharma, Inc. | 1 | $15 |
| Spark Therapeutics, Inc. | 1 | $13 |
How this compares
$1,294 in reported general payments places this provider in the 55th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 41 | $1,505 |
| Ketorolac Tromethamine | 33 | $1,018 |
| Latanoprost | 86 | $911 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 22 | $574 |
| Brimonidine Tartrate | 14 | $521 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 38 | $465 |
| ErythromycinErythromycin Base | 23 | $256 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Warrenton
- Sam MansourWarrenton$77K
- James PaauwLynchburg$7M
- Golnaz JaveyLynchburg$6.7M
- Kapil KapoorNorfolk$4.3M
- Ali TabassianRichmond$2.1M
- Elizabeth Yeu-LinNorfolk$2M
- Ethnie JonesRichmond$2M
- Alan WagnerNorfolk$1.8M
- John SheppardNorfolk$1.2M
- Gustavo CorralesFalls Church$888K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.